Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | UBE2M | P61081 | 1/20 | 0.48 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | CCR8 | P51685 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23711916 | 0.88 | L3MBTL1 (0.50) | L3MBTL1EPHX1EPHX2KMT2AHRH3 | |
| SCHEMBL13191363 | 0.85 | EPHX2 (0.53) | L3MBTL1EPHX1EPHX2MEN1KMT2A | |
| SCHEMBL26095596 | 0.85 | L3MBTL1 (0.48) | L3MBTL1HRH3CHRM1ALDH1A1SIGMAR1 | |
| SCHEMBL13136091 | 0.84 | EPHX1 (0.56) | L3MBTL1EPHX1EPHX2MEN1KMT2A | |
| SCHEMBL16200513 | 0.83 | HRH3 (0.51) | L3MBTL1MEN1KMT2AHRH3KDM4E | |
| SCHEMBL10265277 | 0.83 | SIGMAR1 (0.49) | L3MBTL1EPHX2HRH3CHRM1ALDH1A1 | |
| SCHEMBL17513083 | 0.82 | SMN1; SMN2 (0.57) | L3MBTL1EPHX2HRH3CHRM1SMN1; SMN2 | |
| SCHEMBL28754536 | 0.81 | HRH3 (0.58) | L3MBTL1EPHX1EPHX2HRH3CHRM1 | |
| SCHEMBL23986333 | 0.81 | EPHX2 (0.61) | L3MBTL1EPHX1EPHX2MEN1KMT2A | |
| SCHEMBL18676271 | 0.81 | EPHX1 (0.54) | L3MBTL1EPHX1EPHX2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022255888-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |
| WO-2022253713-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |